MedPath

Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury

Not Applicable
Completed
Conditions
Traumatic Brain Injury (TBI)
Interventions
Behavioral: Cognitive/Neuropsychological Testing
Other: Vestibular/Ocular-Motor Testing
Other: Cervical (Neck) Evaluation
Other: Sleep Evaluation
Other: HDFT MRI
Other: MR Spectroscopy (MRS)
Other: MEG (Magnetoencephalography)
Registration Number
NCT02657135
Lead Sponsor
University of Pittsburgh
Brief Summary

TEAM-TBI (Targeted Evaluation, Action, and Monitoring of Traumatic Brain Injury) is a research study that brings together TBI patients, advanced evaluation methods, and experts in a multi-faceted study to address the heterogeneity of TBI and to evaluate the effects self-help strategies might have on TBI outcomes.

Detailed Description

TEAM-TBI (Targeted Evaluation, Action, and Monitoring of Traumatic Brain Injury) proposes a new approach to clinical trials in TBI that will:

* Evolve diagnostic technology \& treatment

* Improve self-help strategies

* Lower cost and speed for delivery of effective strategies

The TEAM-TBI program proposes an innovative new approach to TBI clinical trials to overcome the limitations of past efforts and achieve long-awaited breakthroughs for TBI survivors. The study will involve a comprehensive 3-4 day intake evaluation, followed by a variety of remotely performed tasks during a 1-6 month follow-up period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
95
Inclusion Criteria
  • 18-60 years of age
  • Fluent in English
  • Documented history of TBI or blast exposure since 2001
Read More
Exclusion Criteria
  • Inability to have MRI
  • Pregnancy
  • History of TIA within last 6 months.
  • Presently involved in open litigation
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
History of Traumatic Brain InjuryVestibular/Ocular-Motor TestingAll participants have a history of TBI. At study outcome participants are provided treatment recommendations that are the result of a consensus meeting of all physician investigators. Follow up care is not provided by this clinical trial.
History of Traumatic Brain InjuryMEG (Magnetoencephalography)All participants have a history of TBI. At study outcome participants are provided treatment recommendations that are the result of a consensus meeting of all physician investigators. Follow up care is not provided by this clinical trial.
History of Traumatic Brain InjuryCervical (Neck) EvaluationAll participants have a history of TBI. At study outcome participants are provided treatment recommendations that are the result of a consensus meeting of all physician investigators. Follow up care is not provided by this clinical trial.
History of Traumatic Brain InjuryCognitive/Neuropsychological TestingAll participants have a history of TBI. At study outcome participants are provided treatment recommendations that are the result of a consensus meeting of all physician investigators. Follow up care is not provided by this clinical trial.
History of Traumatic Brain InjurySleep EvaluationAll participants have a history of TBI. At study outcome participants are provided treatment recommendations that are the result of a consensus meeting of all physician investigators. Follow up care is not provided by this clinical trial.
History of Traumatic Brain InjuryHDFT MRIAll participants have a history of TBI. At study outcome participants are provided treatment recommendations that are the result of a consensus meeting of all physician investigators. Follow up care is not provided by this clinical trial.
History of Traumatic Brain InjuryMR Spectroscopy (MRS)All participants have a history of TBI. At study outcome participants are provided treatment recommendations that are the result of a consensus meeting of all physician investigators. Follow up care is not provided by this clinical trial.
Primary Outcome Measures
NameTimeMethod
The main outcome variable in the study will be the change in Post-Concussion Symptom Scale (PCSS) score from the initial intake evaluation compared to last follow-up evaluation.Up to 6 months
Secondary Outcome Measures
NameTimeMethod
Change in the Satisfaction with Life ScaleUp to 6 months

Trial Locations

Locations (1)

University of Pittsburgh Neurotrauma Clinical Trials Center

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath